RS-102221

RS-102221
Clinical data
Other names	RS-102,221; 8-[5-(2,4-Dimethoxy-5-(4-trifluoromethylphenylsulphonamido)phenyl -5-oxopentyl]-1,3,8-triazaspiro[4.5]decane-2,4-dione
Identifiers
	IUPAC name N-{5-[5-(2,4-dioxo-1,3,8-triazaspiro[4.5]dec-8-yl)pentanoyl] -2,4-dimethoxyphenyl}-4-(trifluoromethyl)benzenesulfonamide;
CAS Number	185376-97-0;
PubChemCID	3693566;
IUPHAR/BPS	187;
ChemSpider	2925610;
ChEMBL	ChEMBL88402;
CompTox Dashboard(EPA)	DTXSID801028164;
Chemical and physical data
Formula	C27H33F3N4O7S
Molar mass	614.64g·mol−1
3D model (JSmol)	Interactive image;
	SMILES c4cc(C(F)(F)F)ccc4S(=O)(=O)Nc(c(OC)cc2OC)cc2C(=O)CCCCN(CC3)CCC13NC(=O)NC1=O;
	InChI InChI=1S/C27H31F3N4O7S/c1-40-22-16-23(41-2)20(33-42(38,39)18-8-6-17(7-9-18)27(28,29)30)15-19(22)21(35)5-3-4-12-34-13-10-26(11-14-34)24(36)31-25(37)32-26/h6-9,15-16,33H,3-5,10-14H2,1-2H3,(H2,31,32,36,37); Key:HZZZZODVDSHQRG-UHFFFAOYSA-N;
	(what is this?)(verify)

RS-102221is a drug developed byHoffmann–La Roche,which was one of the first compounds discovered that acts as a potent and selectiveantagonistat theserotonin 5-HT_2C receptor,with around 100× selectivity over the closely related5-HT_2Aand5-HT_2Breceptors.^[1]It hasanxiolyticeffects in animal studies,^[2]increases the effectiveness ofSSRIantidepressants,^[3]and shows a complex interaction withcocaine,increasing some effects but decreasing others, reflecting a role for the 5-HT_2Creceptor in regulation of thedopaminesignalling system in the brain.^[4]^[5]^[6]^[7]

References

^Bonhaus DW, Weinhardt KK, Taylor M, DeSouza A, McNeeley PM, Szczepanski K, et al. (1997). "RS-102221: a novel high affinity and selective, 5-HT2C receptor antagonist".Neuropharmacology.36(4–5): 621–9.doi:10.1016/s0028-3908(97)00049-x.PMID 9225287.S2CID 24930608.
^Kuznetsova EG, Amstislavskaya TG, Shefer EA, Popova NK (July 2006). "Effect of 5-HT2C receptor antagonist RS 102221 on mouse behavior".Bulletin of Experimental Biology and Medicine.142(1): 76–9.doi:10.1007/s10517-006-0296-8.PMID 17369908.S2CID 36424571.
^Cremers TI, Giorgetti M, Bosker FJ, Hogg S, Arnt J, Mørk A, et al. (October 2004)."Inactivation of 5-HT(2C) receptors potentiates consequences of serotonin reuptake blockade".Neuropsychopharmacology.29(10): 1782–9.doi:10.1038/sj.npp.1300474.PMID 15138437.
^Filip M, Cunningham KA (April 2002). "Serotonin 5-HT(2C) receptors in nucleus accumbens regulate expression of the hyperlocomotive and discriminative stimulus effects of cocaine".Pharmacology, Biochemistry, and Behavior.71(4): 745–56.doi:10.1016/s0091-3057(01)00741-9.PMID 11888566.S2CID 292398.
^Filip M, Cunningham KA (August 2003). "Hyperlocomotive and discriminative stimulus effects of cocaine are under the control of serotonin(2C) (5-HT(2C)) receptors in rat prefrontal cortex".The Journal of Pharmacology and Experimental Therapeutics.306(2): 734–43.doi:10.1124/jpet.102.045716.PMID 12721337.S2CID 8338748.
^Morita K, Hamamoto M, Arai S, Kitayama S, Irifune M, Kawahara M, et al. (September 2005)."Inhibition of serotonin transporters by cocaine and meprylcaine through 5-TH2C receptor stimulation facilitates their seizure activities"(PDF).Brain Research.1057(1–2): 153–60.doi:10.1016/j.brainres.2005.07.049.PMID 16125150.S2CID 30437231.
^Dremencov E, Weizmann Y, Kinor N, Gispan-Herman I, Yadid G (February 2006). "Modulation of dopamine transmission by 5HT2C and 5HT3 receptors: a role in the antidepressant response".Current Drug Targets.7(2): 165–75.doi:10.2174/138945006775515491.PMID 16475958.

[1] Bonhaus DW, Weinhardt KK, Taylor M, DeSouza A, McNeeley PM, Szczepanski K, et al. (1997). "RS-102221: a novel high affinity and selective, 5-HT2C receptor antagonist".Neuropharmacology.36(4–5): 621–9.doi:10.1016/s0028-3908(97)00049-x.PMID 9225287.S2CID 24930608.

[2] Kuznetsova EG, Amstislavskaya TG, Shefer EA, Popova NK (July 2006). "Effect of 5-HT2C receptor antagonist RS 102221 on mouse behavior".Bulletin of Experimental Biology and Medicine.142(1): 76–9.doi:10.1007/s10517-006-0296-8.PMID 17369908.S2CID 36424571.

[3] Cremers TI, Giorgetti M, Bosker FJ, Hogg S, Arnt J, Mørk A, et al. (October 2004)."Inactivation of 5-HT(2C) receptors potentiates consequences of serotonin reuptake blockade".Neuropsychopharmacology.29(10): 1782–9.doi:10.1038/sj.npp.1300474.PMID 15138437.

[4] Filip M, Cunningham KA (April 2002). "Serotonin 5-HT(2C) receptors in nucleus accumbens regulate expression of the hyperlocomotive and discriminative stimulus effects of cocaine".Pharmacology, Biochemistry, and Behavior.71(4): 745–56.doi:10.1016/s0091-3057(01)00741-9.PMID 11888566.S2CID 292398.

[5] Filip M, Cunningham KA (August 2003). "Hyperlocomotive and discriminative stimulus effects of cocaine are under the control of serotonin(2C) (5-HT(2C)) receptors in rat prefrontal cortex".The Journal of Pharmacology and Experimental Therapeutics.306(2): 734–43.doi:10.1124/jpet.102.045716.PMID 12721337.S2CID 8338748.

[6] Morita K, Hamamoto M, Arai S, Kitayama S, Irifune M, Kawahara M, et al. (September 2005)."Inhibition of serotonin transporters by cocaine and meprylcaine through 5-TH2C receptor stimulation facilitates their seizure activities"(PDF).Brain Research.1057(1–2): 153–60.doi:10.1016/j.brainres.2005.07.049.PMID 16125150.S2CID 30437231.

[7] Dremencov E, Weizmann Y, Kinor N, Gispan-Herman I, Yadid G (February 2006). "Modulation of dopamine transmission by 5HT2C and 5HT3 receptors: a role in the antidepressant response".Current Drug Targets.7(2): 165–75.doi:10.2174/138945006775515491.PMID 16475958.

[1]

[2]

[3]

[4]

[5]

[6]

[7]

See also

References